SCHEMBL30950241

SCHEMBL30950241

Cc1ccc2[nH]ncc2c1Oc1cccc2c(C3CNCCN3C(=O)OC(C)(C)C)c(C#N)c(Cl)nc12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30950222 0.88 PRMT5 (0.31) —
SCHEMBL30950217 0.81 KCNH2 (0.35) —
SCHEMBL28655570 0.81 KCNH2 (0.35) —
SCHEMBL28673314 0.75 ALDH1A1 (0.34) —
SCHEMBL30950256 0.75 ALDH1A1 (0.34) —
SCHEMBL28664682 0.73 KCNH2 (0.36) —
SCHEMBL30950196 0.73 KCNH2 (0.36) —
SCHEMBL30950272 0.73 KCNH2 (0.36) —
SCHEMBL28929882 0.73 KCNH2 (0.36) —
SCHEMBL30950231 0.72 KCNH2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113637005-B KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2024-05-24 — — CN disclosed
Send feedback